-
Aug 16, 2024 | 
kornferry.com | Greg Button |Kae Robertson |Katie Bell
The doors to the emergency room swing open. Doctors rush in with a patient on a stretcher, shouting details about injuries and vital signs. Nurses scramble to load up syringes and get surgical tools ready. What goes on between doctors, nurses, and their patients has long intrigued Hollywood—enough to result in many shows and movies. Now, one hospital chain wants in on the action.
-
Oct 9, 2023 | 
firstwordhealthtech.com | Katie Bell
DeepScribe unveiled on Monday a customisation offering allowing clinicians to adapt its artificial intelligence (AI) scribe to their custom workflows. The company said it is the first AI scribe to generate personalised, specialty-specific notes within seconds of completing a visit. "After capturing millions of patient encounters over the last five years, one thing is very clear: not all specialties and not all notes are built equal," remarked CEO Akilesh Bapu.
-
Oct 9, 2023 | 
firstwordhealthtech.com | Katie Bell
Ref: FirstWord HealthTechPublished: October 09, 2023NuraLogix announced the availability of its Anura telehealth solution for integration into healthcare professionals' telehealth offerings, enabling the real-time assessment of vital signs during video consultation sessions.
-
Oct 6, 2023 | 
firstwordhealthtech.com | Katie Bell
Ref: Business WirePublished: October 06, 2023Akili announced on Friday that Matt Franklin has been appointed to serve as CEO of the digital therapeutics (DTx) company and as a member of its board of directors, effective October 5. He replaced Eddie Martucci who transitioned to the role of board chair, replacing former board chair Chamath Palihapitiya, who resigned from the board on October 4. Franklin's "stepping into the role of CEO comes at an optimal time," said Martucci.
-
Oct 6, 2023 | 
firstwordhealthtech.com | Katie Bell
Ref: GE HealthcarePublished: October 06, 2023GE HealthCare on Friday announced the US launch of the artificial intelligence (AI)-driven Caption Guidance feature on its Venue Family point-of-care ultrasound systems. The AI technology provides real-time guidance to users for capturing diagnostic-quality cardiac images.
-
Oct 2, 2023 | 
firstwordhealthtech.com | Katie Bell
Healthcare data and technology solutions provider Veradigm and Holmusk announced on Monday a new phase in their strategic collaboration that aims to enhance care delivery and improve behavioural health outcomes. Veradigm, formerly Allscripts Healthcare Solutions, led Holmusk’s Series B financing in January that raised $45 million to expand the latter's NeuroBlu database of real-world clinical data for the behavioural health industry.
-
Oct 2, 2023 | 
firstwordhealthtech.com | Katie Bell
Ref: FDA, NASDAQ, MorningstarPublished: October 02, 2023The FDA granted de novo marketing authorisation for Invitae's Common Hereditary Cancers Panel test to help detect hundreds of genetic variants associated with an increased risk of developing certain cancers. The in vitro diagnostic test - the first of its kind to be granted marketing authorisation in the US - can also help identify potentially cancer-associated hereditary variants in individuals already diagnosed with cancer.
-
Sep 29, 2023 | 
firstwordhealthtech.com | Katie Bell
Ref: GlobeNewswire, Fidelity, MarketWatch, DutchNews.nlPublished: September 29, 2023Renovaro Biosciences announced on Friday that it agreed to combine with artificial intelligence (AI) company GEDi Cube in a stock-for-stock acquisition. The transaction, in which GEDi Cube will become a Renovaro subsidiary, has been approved by the companies' boards and is expected to close late in the fourth quarter or early next year, subject to Renovaro stockholder approval.
-
Sep 19, 2023 | 
firstwordhealthtech.com | Katie Bell
DeepMind announced on Tuesday that a study published in Science showed that its new artificial intelligence (AI) model, called AlphaMissense, could classify the effects of missense mutations, in which a single letter of the genetic code changes. The company has made the AlphaMissense catalogue of mutations freely available to the scientific community and open sourced the model code for AlphaMissense.
-
May 8, 2023 | 
firstwordhealthtech.com | Katie Bell
Samsung Electronics announced on Monday the FDA clearance of the irregular heart rhythm notification (IHRN) feature of its health monitor app, which together with the app's existing on-demand electrocardiogram (ECG) function, monitors heart rhythms suggestive of atrial fibrillation (AF) from the wrist via the company's Galaxy Watch. The IHRN feature "enables users to receive a more holistic understanding of their cardiovascular and overall health" said Hon Pak, head of the digital health team.
